Frank Torti's Net Worth
$21.5 Million
Who is Frank Torti?
Frank Torti has an estimated net worth of $21.5 Million. This is based on reported shares across multiple companies, which include Urovant Sciences Ltd., Arbutus Biopharma Corp, Myovant Sciences Ltd., Immunovant, Inc., and Axovant Sciences Ltd..
SEC CIK
Frank Torti's CIK is 0001647805
Past Insider Trading and Trends
2019 was Frank Torti's most active year for acquiring shares with 8 total transactions. Frank Torti's most active month to acquire stocks was the month of March. 2022 saw Frank Torti paying a total of $116,200.00 for 1,055,539 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Immunovant, Inc. (IMVT) Snapshot price: $34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.37% | 120.4K |
—
|
—
| 635.67K |
Apr 2
| |||
Form 4
| +30.99% | 121.92K |
—
|
—
| 515.27K |
Apr 12
| |||
Form 4
| +5.36% | 20K |
$5.81 | $116,200.00 | 393.36K |
Sep 29
| |||
Form 4
| +152.74% | 225.63K |
—
|
—
| 373.36K |
Aug 17
| |||
Form 4
| +210.35% | 100.13K |
—
|
—
| 147.73K |
Jan 10
| |||
Form 4
| +67.61% | 19.2K |
—
|
—
| 47.6K |
Mar 19
| |||
Form 4
|
∞
| 28.4K |
—
|
—
| 28.4K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |